Literature DB >> 15735082

Dietary threonine restriction specifically reduces intestinal mucin synthesis in rats.

Magali Faure1, Denis Moënnoz, Franck Montigon, Christine Mettraux, Denis Breuillé, Olivier Ballèvre.   

Abstract

We determined whether the steady-state levels of intestinal mucins are more sensitive than total proteins to dietary threonine intake. For 14 d, male Sprague-Dawley rats (158 +/- 1 g, n = 32) were fed isonitrogenous diets (12.5% protein) containing 30% (group 30), 60% (group 60), 100% (control group), or 150% (group 150) of the theoretical threonine requirement for growth. All groups were pair-fed to the mean intake of group 30. The mucin and mucosal protein fractional synthesis rates (FSR) did not differ from controls in group 60. By contrast, the mucin FSR was significantly lower in the duodenum, ileum, and colon of group 30 compared with group 100, whereas the corresponding mucosal protein FSR did not differ. Because mucin mRNA levels did not differ between these 2 groups, mucin production in group 30 likely was impaired at the translational level. Our results clearly indicate that restriction of dietary threonine significantly and specifically impairs intestinal mucin synthesis. In clinical situations associated with increased threonine utilization, threonine availability may limit intestinal mucin synthesis and consequently reduce gut barrier function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15735082     DOI: 10.1093/jn/135.3.486

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  26 in total

1.  Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting.

Authors:  Richard D Semba; Indi Trehan; Marta Gonzalez-Freire; Klaus Kraemer; Ruin Moaddel; M Isabel Ordiz; Luigi Ferrucci; Mark J Manary
Journal:  Adv Nutr       Date:  2016-09-15       Impact factor: 8.701

Review 2.  Oxygen metabolism and barrier regulation in the intestinal mucosa.

Authors:  Louise E Glover; J Scott Lee; Sean P Colgan
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

Review 3.  Post-Infectious Irritable Bowel Syndrome.

Authors:  Yeong Yeh Lee; Chandramouli Annamalai; Satish S C Rao
Journal:  Curr Gastroenterol Rep       Date:  2017-09-25

Review 4.  Diet in the pathogenesis and treatment of inflammatory bowel diseases.

Authors:  Dale Lee; Lindsey Albenberg; Charlene Compher; Robert Baldassano; David Piccoli; James D Lewis; Gary D Wu
Journal:  Gastroenterology       Date:  2015-01-15       Impact factor: 22.682

5.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

6.  Splanchnic tissues respond differently when piglets are offered a diet 30 % deficient in total sulfur amino acid for 10 days.

Authors:  José Alberto Conde-Aguilera; Nathalie Le Floc'h; Isabelle Le Huërou-Luron; Yves Mercier; Sophie Tesseraud; Louis Lefaucheur; Jaap van Milgen
Journal:  Eur J Nutr       Date:  2015-09-03       Impact factor: 5.614

7.  L-Threonine induces heat shock protein expression and decreases apoptosis in heat-stressed intestinal epithelial cells.

Authors:  Christine H Baird; Stefanie Niederlechner; Ryan Beck; Alyssa R Kallweit; Paul E Wischmeyer
Journal:  Nutrition       Date:  2013 Nov-Dec       Impact factor: 4.008

8.  A diet containing whey protein, glutamine, and TGFbeta modulates gut protein metabolism during chemotherapy-induced mucositis in rats.

Authors:  Nabile Boukhettala; Ayman Ibrahim; Sophie Claeyssens; Magali Faure; Florence Le Pessot; Jacques Vuichoud; Alain Lavoinne; Denis Breuillé; Pierre Déchelotte; Moïse Coëffier
Journal:  Dig Dis Sci       Date:  2009-11-13       Impact factor: 3.199

9.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09

10.  The immune modifying effects of amino acids on gut-associated lymphoid tissue.

Authors:  Megan R Ruth; Catherine J Field
Journal:  J Anim Sci Biotechnol       Date:  2013-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.